Cytarabine: Difference between revisions
Jump to navigation
Jump to search
imported>Robert Badgett (Added mesh references and czmed) |
imported>Meg Taylor No edit summary |
||
| (One intermediate revision by one other user not shown) | |||
| Line 1: | Line 1: | ||
{{subpages}} | {{subpages}} | ||
''' | In [[medicine]], '''cytaribine''' is a "[[pyrimidine]] nucleoside analog that is used mainly in the treatment of [[leukemia]], especially acute non-lymphoblastic [[leukemia]]. It is an antimetabolite [[antineoplastic agent]] that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties."<ref>{{MeSH}}</ref> | ||
==References== | ==References== | ||
{{reflist}} | |||
==External links | ==External links== | ||
{{CZMed}} | {{CZMed}} | ||
Latest revision as of 02:25, 7 October 2013
In medicine, cytaribine is a "pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. It is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties."[1]
References
- ↑ Anonymous (2024), Cytarabine (English). Medical Subject Headings. U.S. National Library of Medicine.
External links
The most up-to-date information about Cytarabine and other drugs can be found at the following sites.
- Cytarabine - FDA approved drug information (drug label) from DailyMed (U.S. National Library of Medicine).
- Cytarabine - Drug information for consumers from MedlinePlus (U.S. National Library of Medicine).
- Cytarabine - Detailed information from DrugBank.